Top

Published in:

01-12-2020 | Antipsychotics | Commentary

Cardiovascular risk management in patients using antipsychotics: it is time to take action

Authors: Erik W. M. A. Bischoff, Kirsti M. Jakobs, Willem J. J. Assendelft

Published in: BMC Medicine | Issue 1/2020

Excerpt

The study from Lai and colleagues, recently published in BMC Medicine, provides interesting new insights on sex-related associations between antipsychotic use and acute ischemic heart disease [1]. The authors demonstrated that antipsychotic use was associated with a 32% increased hazard rate of acute ischemic heart disease (IHD) among women (95% CI 1.05–1.67), but not among men. In their Hong Kong primary care population, almost 2% were prescribed antipsychotic drugs. …

Lai FTT, Guthrie B, Mercer SW, Smith DJ, Yip BHK, Chung GKK, et al. Association between antipsychotic use and acute ischemic heart disease in women but not in men: a retrospective cohort study of over one million primary care patients. BMC Med. 2020. https://doi.org/10.1186/s12916-020-01765-w.

Marston L, Nazareth I, Petersen I, Walters K, Osborn DP. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open. 2014;4(12):e006135.CrossRefPubMedPubMedCentral

Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–80.CrossRefPubMedPubMedCentral

(NICE) National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. Clinical guideline [CG181] 2014 [updated September 2016. Available from: www.nice.org.uk/guidance/cg181. Accessed 28 Sept 2020.

Baller JB, McGinty EE, Azrin ST, Juliano-Bult D, Daumit GL. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. BMC Psychiatry. 2015;15:55.CrossRefPubMedPubMedCentral

Jakobs KM, Posthuma A, de Grauw WJC, Schalk BWM, Akkermans RP, Lucassen P, et al. Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice. BMC Fam Pract. 2020;21(1):153.CrossRefPubMedPubMedCentral

Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64–77.CrossRefPubMedPubMedCentral

Gillies D, Buykx P, Parker AG, Hetrick SE. Consultation liaison in primary care for people with mental disorders. Cochrane Database Syst Rev. 2015;9:CD007193.

Osborn D, Burton A, Hunter R, Marston L, Atkins L, Barnes T, et al. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial. Lancet Psychiatry. 2018;5(2):145–54.CrossRefPubMed

10.

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337. https://doi.org/10.1136/bmj.a1655.

Title: Cardiovascular risk management in patients using antipsychotics: it is time to take action
Authors: Erik W. M. A. Bischoff
Kirsti M. Jakobs
Willem J. J. Assendelft
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Antipsychotics
Care
Antipsychotics
Published in: BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-020-01811-7

At a glance: The STEP trials

Springer Medicine

Cardiovascular risk management in patients using antipsychotics: it is time to take action

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Q&A: The novel coronavirus outbreak causing COVID-19

A comparison of the associations between adiposity and lipids in Malawi and the United Kingdom

Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial

The three numbers you need to know about healthcare: the 60-30-10 Challenge

Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study

Caring for Africa’s sickle cell children: will we rise to the challenge?